首页> 美国卫生研究院文献>Springer Open Choice >Top-Down and Bottom-Up Identification of Proteins by Liquid Extraction Surface Analysis Mass Spectrometry of Healthy and Diseased Human Liver Tissue
【2h】

Top-Down and Bottom-Up Identification of Proteins by Liquid Extraction Surface Analysis Mass Spectrometry of Healthy and Diseased Human Liver Tissue

机译:通过健康和患病人体组织的液体萃取表面分析质谱从上至下和从下至上识别蛋白质

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Liquid extraction surface analysis mass spectrometry (LESA MS) has the potential to become a useful tool in the spatially-resolved profiling of proteins in substrates. Here, the approach has been applied to the analysis of thin tissue sections from human liver. The aim was to determine whether LESA MS was a suitable approach for the detection of protein biomarkers of nonalcoholic liver disease (nonalcoholic steatohepatitis, NASH), with a view to the eventual development of LESA MS for imaging NASH pathology. Two approaches were considered. In the first, endogenous proteins were extracted from liver tissue sections by LESA, subjected to automated trypsin digestion, and the resulting peptide mixture was analyzed by liquid chromatography tandem mass spectrometry (LC-MS/MS) (bottom-up approach). In the second (top-down approach), endogenous proteins were extracted by LESA, and analyzed intact. Selected protein ions were subjected to collision-induced dissociation (CID) and/or electron transfer dissociation (ETD) mass spectrometry. The bottom-up approach resulted in the identification of over 500 proteins; however identification of key protein biomarkers, liver fatty acid binding protein (FABP1), and its variant (Thr→Ala, position 94), was unreliable and irreproducible. Top-down LESA MS analysis of healthy and diseased liver tissue revealed peaks corresponding to multiple (~15–25) proteins. MS/MS of four of these proteins identified them as FABP1, its variant, α-hemoglobin, and 10 kDa heat shock protein. The reliable identification of FABP1 and its variant by top-down LESA MS suggests that the approach may be suitable for imaging NASH pathology in sections from liver biopsies.>Graphical Abstract
机译:液体萃取表面分析质谱(LESA MS)有潜力成为对基质中蛋白质进行空间分辨谱分析的有用工具。在这里,该方法已应用于分析人类肝脏的薄组织切片。目的是确定LESA MS是否是检测非酒精性肝病(非酒精性脂肪性肝炎,NASH)的蛋白质生物标记物的合适方法,以期最终开发出可用于成像NASH病理的LESA MS。考虑了两种方法。首先,通过LESA从肝脏组织切片中提取内源蛋白,进行自动胰蛋白酶消化,然后通过液相色谱串联质谱法(LC-MS / MS)(自下而上的方法)分析所得的肽混合物。在第二种方法(自上而下的方法)中,LESA提取了内源蛋白,并对其进行了完整分析。对选定的蛋白质离子进行碰撞诱导解离(CID)和/或电子转移解离(ETD)质谱分析。自下而上的方法导致鉴定出500多种蛋白质。但是,关键蛋白质生物标志物,肝脂肪酸结合蛋白(FABP1)及其变体(Thr→Ala,位置94)的鉴定是不可靠且不可重复的。对健康和患病肝脏组织的自上而下的LESA MS分析显示出对应于多种(〜15–25)蛋白的峰。这些蛋白质中有四种的MS / MS鉴定为FABP1,其变体,α-血红蛋白和10kDa热激蛋白。自上而下的LESA MS对FABP1及其变体的可靠鉴定表明,该方法可能适用于在肝活检切片中对NASH病理成像。<!-fig ft0-> <!-fig @ position =“ anchor “ mode = article f4-> <!-fig mode =” anchored“ f5-> >图形摘要<!-fig / graphic | fig / alternatives / graphic mode =” anchored“ m1-> < !-标题a7->ᅟ

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号